Breast Cancer News

New insight into breast cancer resistance to hormone therapyMar 5, 2020
New findings suggest that a therapeutic approach must combine two different drugs, a SERD to degrade ER and a MEK inhibitor to inhibit Ras downstream signaling, in order to effectively treat neurofibromin-depleted ER+ breast cancer.
Protein AKAP8 suppresses breast cancer metastasisJan 24, 2020
A protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors.
Mechanism reprograms breast cancer to become metastaticDec 11, 2019
A researchers haves unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior.
Susan G. Komen® honors Dr. Matthew Ellis with Brinker AwardOct 3, 2019
Dr. Matthew Ellis has been awarded the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research.
Cell roles in immunotherapy-resistant breast cancer profiledAug 26, 2019
To better understand the specific roles different immune cell types play, a multi-institutional team profiled the immune cell composition of multiple murine models and clinical datasets of triple negative breast cancers.
Cancer Prevention & Research Institute of Texas awards grantsFeb 22, 2019
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
Discovery explains breast cancer cells’ ability to adapt, surviveJan 28, 2019
A team led by researchers at Baylor College of Medicine has discovered that breast cancer cells can shift between two forms of the cell surface molecule CD44, CD44s and CD44v.
DPYSL3 an outlier gene in triple-negative breast cancerNov 26, 2018
Researchers have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.
Repurposing FDA-approved drugs to fight breast cancerNov 16, 2018
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Novel strategy may reduce breast cancer bone metastasisNov 12, 2018
Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles' heel for these cancer cells.